Ironwood Pharmaceuticals, Inc. (IRWD)

NASDAQ: IRWD · Real-Time Price · USD

3.570

+0.020 (0.56%)

At close: Oct 22, 2026, 4:00 PM EDT

3.560

-0.010 (-0.28%)

After-hours: Oct 22, 2026, 7:38 PM EDT

Ironwood Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	389.32	296.15	351.41	442.74	410.6	413.75
Revenue Growth	26.19%	-15.72%	-20.63%	7.83%	-0.76%	6.22%
Cost of Revenue	88.69	95.14	111.42	104.79	44.27	70.41
Gross Profit	300.62	201.02	239.99	337.95	366.33	343.35
Selling, General & Admin	64.35	82.06	143.63	142.11	115.99	111.13
Operating Expenses	64.35	82.06	143.63	142.11	115.99	111.13
Operating Income	236.27	118.95	96.36	195.84	250.34	232.22
Interest Expense	-32.66	-32.75	-33.29	-21.38	-7.6	-31.15
Interest & Investment Income	5.67	4.08	4.47	18.97	9.5	0.73
Other Non Operating Income (Expenses)	0.01	-	0.25	-0.23	0.18	-1.18
EBT Excluding Unusual Items	209.29	90.28	67.79	193.2	252.42	200.61
Merger & Restructuring Charges	-1.91	-20.26	-2.59	-45.82	-	0.04
Pretax Income	207.38	70.03	65.2	-948.07	252.42	200.66
Income Tax Expense	77.51	46.01	64.32	83.49	77.36	-327.79
Earnings From Continuing Operations	129.87	24.02	0.88	-1,032	175.07	528.45
Net Income to Company	129.87	24.02	0.88	-1,032	175.07	528.45
Minority Interest in Earnings	-	-	-	29.32	-	-
Net Income	129.87	24.02	0.88	-1,002	175.07	528.45
Net Income to Common	129.87	24.02	0.88	-1,002	175.07	528.45
Net Income Growth	-	2629.20%	-	-	-66.87%	397.71%
Shares Outstanding (Basic)	163	162	159	155	154	162
Shares Outstanding (Diluted)	166	163	160	155	186	164
Shares Change	3.27%	1.81%	2.99%	-16.57%	13.32%	2.34%
EPS (Basic)	0.80	0.15	0.01	-6.45	1.13	3.26
EPS (Diluted)	0.79	0.15	0.01	-6.45	0.96	3.21
EPS Growth	-	2583.01%	-	-	-69.98%	386.36%

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	185.55	127.01	103.41	183.15	273.63	261.63
Free Cash Flow Per Share	1.12	0.78	0.65	1.18	1.47	1.59
Gross Margin	77.22%	67.88%	68.29%	76.33%	89.22%	82.98%
Operating Margin	60.69%	40.17%	27.42%	44.23%	60.97%	56.12%
Profit Margin	33.36%	8.11%	0.25%	-226.37%	42.64%	127.72%
Free Cash Flow Margin	47.66%	42.89%	29.43%	41.37%	66.64%	63.23%
EBITDA	238.11	120.83	98.37	197.41	251.76	233.74
EBITDA Margin	61.16%	40.80%	27.99%	44.59%	61.31%	56.49%
D&A For EBITDA	1.84	1.88	2.01	1.58	1.42	1.52
EBIT	236.27	118.95	96.36	195.84	250.34	232.22
EBIT Margin	60.69%	40.17%	27.42%	44.23%	60.97%	56.12%
Effective Tax Rate	37.38%	65.70%	98.65%	-	30.65%	-
Revenue as Reported	389.32	296.15	351.41	442.74	410.6	413.75

SEC Filings: 10-K · 10-Q